IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds - Fig 1

a. Distribution of IgM anti-OxPS among cases and controls. 0 = controls who did not develop CVD during the follow up time, 1 = controls who did develop CVD. Cases hade significantly lower levels than controls (p = 0.047). Differences were more pronounced when highest quartile was compared with the other quartiles. b. Distribution of IgM anti-OxPS among women, cases and controls. 0 = controls who did not develop CVD during the follow up time, 1 = controls who did develop CVD. Cases hade significantly lower levels than controls (p = 0.047). Differences were more pronounced when highest quartile was compared with the other quartiles. c. Distribution of IgM anti-OxPS among men, cases and controls. 0 = controls who did not develop CVD during the follow up time, 1 = controls who did develop CVD. Cases hade significantly lower levels than controls (p = 0.047). Differences were more pronounced when highest quartile was compared with the other quartiles.